DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,294 filers reported holding DANAHER CORPORATION in Q4 2018. The put-call ratio across all filers is 1.15 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $875,000 | -57.6% | 4,062 | -65.2% | 0.55% | +59.4% |
| Q2 2020 | $2,064,000 | +192.8% | 11,675 | +129.3% | 0.35% | +3.6% |
| Q1 2020 | $705,000 | -58.1% | 5,092 | -53.5% | 0.34% | +63.4% |
| Q4 2019 | $1,682,000 | +4.4% | 10,958 | -1.7% | 0.20% | +2.5% |
| Q3 2019 | $1,611,000 | -4.3% | 11,153 | -5.3% | 0.20% | +0.5% |
| Q2 2019 | $1,683,000 | +2.5% | 11,778 | -5.3% | 0.20% | +6.4% |
| Q1 2019 | $1,642,000 | +142.5% | 12,437 | +89.6% | 0.19% | -0.5% |
| Q4 2018 | $677,000 | -99.9% | 6,561 | -45.7% | 0.19% | -42.2% |
| Q3 2018 | $742,285,000 | +54002.4% | 12,088 | -13.1% | 0.32% | +142.5% |
| Q2 2018 | $1,372,000 | -43.6% | 13,907 | -44.0% | 0.13% | -42.2% |
| Q1 2018 | $2,431,000 | +249.8% | 24,824 | +231.6% | 0.23% | -13.4% |
| Q4 2017 | $695,000 | -2.8% | 7,485 | -10.3% | 0.27% | +10.7% |
| Q3 2017 | $715,000 | +7.8% | 8,341 | +6.1% | 0.24% | +1.3% |
| Q2 2017 | $663,000 | +360.4% | 7,861 | +366.8% | 0.24% | +359.6% |
| Q1 2017 | $144,000 | – | 1,684 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
| WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
| Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
| Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
| CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
| Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
| Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
| Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
| Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
| Third Point | 3,570,000 | $494,124,000 | 7.88% |